Pages that link to "Q27662237"
Jump to navigation
Jump to search
The following pages link to The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function (Q27662237):
Displaying 31 items.
- Lumican: a new inhibitor of matrix metalloproteinase-14 activity (Q24305431) (← links)
- Ancylostoma ceylanicum Excretory–Secretory Protein 2 Adopts a Netrin-Like Fold and Defines a Novel Family of Nematode Proteins (Q27667068) (← links)
- Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential (Q27676429) (← links)
- Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTURE (Q27678085) (← links)
- Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes (Q27680082) (← links)
- Affinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPs (Q28542042) (← links)
- Intrinsic dynamics study identifies two amino acids of TIMP-1 critical for its LRP-1-mediated endocytosis in neurons. (Q33905528) (← links)
- Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)) (Q33946167) (← links)
- TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain (Q34305749) (← links)
- Enzymatic turnover of macromolecules generates long-lasting protein-water-coupled motions beyond reaction steady state (Q34752624) (← links)
- Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases. (Q35063432) (← links)
- Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase (Q35588436) (← links)
- Correlated structural kinetics and retarded solvent dynamics at the metalloprotease active site (Q35840878) (← links)
- Matrix metalloproteinases as breast cancer drivers and therapeutic targets (Q35892721) (← links)
- Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities (Q36919032) (← links)
- Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14. (Q36987704) (← links)
- Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity. (Q37089575) (← links)
- Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis (Q37202720) (← links)
- Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression (Q37693503) (← links)
- Structural Studies of Matrix Metalloproteinase by X-Ray Diffraction (Q38904219) (← links)
- Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology (Q41374334) (← links)
- Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors (Q41785296) (← links)
- Crystallization and preliminary X-ray crystallographic analysis of the catalytic domain of membrane type 1 matrix metalloproteinase (Q41981745) (← links)
- Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer (Q42720277) (← links)
- Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer (Q47394596) (← links)
- Solvent water interactions within the active site of the membrane type I matrix metalloproteinase (Q47738424) (← links)
- Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution (Q51044896) (← links)
- Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14. (Q52688539) (← links)
- Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell (Q56889045) (← links)
- The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases (Q58802523) (← links)
- Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation (Q92879530) (← links)